Target intelligence / Profile preview

Transmembrane protein 138 (TMEM138)

Target
TMEM138
Molecular classification
Other (Ciliary transmembrane protein; not a classical receptor, enzyme, transporter, or ion channel)
01

Overview

Transmembrane protein 138 (TMEM138) is a 162-amino acid, four-pass transmembrane protein of about 18.4 kDa, highly conserved among vertebrates and localized primarily to the photoreceptor connecting cilium, which is structurally analogous to the transition zone of primary cilia[1][2][4]. TMEM138 forms part of a membrane complex with Ahi1 and Tmem231 and interacts directly with rhodopsin, facilitating its trafficking between the inner and outer segments of photoreceptor cells, which is essential for normal photoreceptor function and the maintenance of visual capacity[1][2][4]. Loss of TMEM138 disrupts the ciliary complex, mislocalizes rhodopsin, and causes a failure in photoreceptor outer segment morphogenesis, ultimately leading to rapid photoreceptor degeneration and is implicated in ciliopathies including Joubert syndrome (JBTS16)[1][2][4]. TMEM138 is not currently considered a therapeutic drug target, nor are there drugs known to interact with it, but pathogenic variants have clear genetic and mechanistic relevance in inherited retinal and ciliary disorders[3].

Other names
TMEM138HSPC196HSPC198JBTS16
02

Biological functions

Ciliary traffickingPhotoreceptor outer segment biogenesisRegulation of rhodopsin localizationProtein complex assembly in photoreceptor connecting cilium
03

Disease associations

Ciliopathy (notably Joubert syndrome and related disorders)Photoreceptor degenerative diseaseRetinal dystrophy

Beyond the preview

Go deeper on Transmembrane protein 138 (TMEM138).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 138 (TMEM138).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call